Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression

American Journal of Transplantation

Volumn 8, Issue 2, 2008, Pages 338-347

  Trzonkowski, P ^a,b   Zilvetti, M ^a   Chapman, S ^a   Wieckiewicz J ^a   Sutherland, A ^a   Friend, P ^a   Wood, K J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Alemtuzumab; CAMPATH 1H; Human; Memory; T cells; Tolerance suppression anergy; Transplantation

Indexed keywords

ALEMTUZUMAB; CD28 ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ARTICLE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPLETION; GRAFT REJECTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LYMPHOCYTOPENIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, CD28; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKINS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 38149086827     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02078.x     Document Type: Article

References (29)

1. Wu Z, Bensinger SJ, Zhang J, Chen C et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004 10 : 87 92.
2. Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5 : 465 474.
3. Trzonkowski P, Zilvetti M, Friend P, Wood KJ. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Transplantation 2006 82 : 1342 1351.
4. Neujahr DC, Chen C, Huang X et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006 176 : 4632 4639.
5. Calne R, Moffatt SD, Friend PJ et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999 68 : 1613 1616.
6. Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003 76 : 120 129.
7. Kirk AD, Mannon RB, Kleiner DE et al. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation 2005 80 : 1051 1059.
8. Knechtle SJ. Development of tolerogenic strategies in the clinic. Philos Trans R Soc Lond B Biol Sci 2005 360 : 1739 1746.
9. Shapiro R, Basu A, Tan H et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J AmColl Surg 2005 200 : 505 515.
10. Watson CJ, Bradley J, Friend PJ et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation - efficacy and safety at five years. Am J Transplant 2005 5 : 1347 1353.
11. Flechner SM, Friend PJ, Brockmann J et al. Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am J Transplant 2005 5 : 3009 3014.
12. + memory T-cells in vitro with immunosuppressants. Transplantation 2006 82 : 1352 1361.
13. Cox AL, Thompson SA, Jones JL et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur J Immunol 2005 35 : 3332 3342.
14. + lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 2006 17 : 294 304.
15. Akbar AN, Beverley PC, Salmon M. Will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol 2004 4 : 737 743.
16. Adibzadeh M, Pohla H, Rehbein A, Pawelec G. Long-term culture of monoclonal human T lymphocytes: Models for immunosenescence? Mech Ageing Dev 1995 83 : 171 183.
17. Grubeck-Loebenstein B, Lechner H, Trieb K. Long-term in vitro growth of human T cell clones: Can postmitotic 'senescent' cell populations be defined? Int Arch Allergy Immunol 1994 104 : 232 239.
18. Effros RB. Replicative senescence in the immune system: Impact of the Hayflick limit on T cell function in the elderly. Human genetics 98: Ageing and senescence. Am J Hum Genet 1998 62 : 1 5.
19. Hadrup SR, Strindhall J, Kollgaard T et al. Longitudinal studies of clonally expanded CD8 T-cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T-cells in the very elderly. J Immunol 2006 176 : 2645 2653.
20. Trzonkowski P, Mysliwska J, Szmit E et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 2003 21 : 3826 3836.
21. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: The prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000 18 : 1717 1720.
22. + memory T-cells in aged individuals. Immunol Rev 2005 205 : 170 189.
23. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996 10 : F17 F22.
24. + T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001 2 : 415 422.
25. +CD28- T suppressor cells. Hum Immunol 2004 65 : 1297 1306.
26. Suciu-Foca N, Manavalan JS, Scotto L et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: Review. Int Immunopharmacol 2005 5 : 7 11.
27. + regulatory T-cells. Clin Immunol 2006 120 : 247 259.
28. Ciancio G, Burke GW, Gaynor JJ et al. A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation 2005 80 : 457 465.
29. + regulatory T-cells. Blood 2005 105 : 4743 4748.